STATFACTS · amyl

Acute Myeloid Leukemia (AML)

Open original source → · Download preserved record

Source-level population statistics, not individual predictions. Different measures and subtypes are not interchangeable.

amyl

name

source title

Cancer Stat Facts: Leukemia — Acute Myeloid Leukemia (AML)

source

id: amyl
name: Acute Myeloid Leukemia (AML)
url: https://seer.cancer.gov/statfacts/html/amyl.html
file: raw/amyl.html
sha256: 2888db55c5050126d61c0bc0bc804c1c090088564bd3236d50bf8668d9523319
bytes: 81618
retrieved at: 2026-09-09T23:18:23.288538+00:00

kind

cancer_or_subtype

historical survival

metric

relative_survival

horizon years

estimate type

observed_published_estimate

x axis

diagnosis_year

cohort

registry: SEER 8
diagnosis years: 1975
2018
race: All races
sex: Both sexes
age range: Source null
age adjustment: Source null
source footnote: SEER 8 5-Year Relative Survival Percent from 1975–2018, All Races, Both Sexes. Modeled trend lines were calculated from the underlying rates using the Joinpoint Survival Model Software.
stage: All stages

points

diagnosis year
1975
percent
5.45
diagnosis year
1976
percent
4.67
diagnosis year
1977
percent
8.28
diagnosis year
1978
percent
8.08
diagnosis year
1979
percent
7.86
diagnosis year
1980
percent
6.98
diagnosis year
1981
percent
7.52
diagnosis year
1982
percent
8.79
diagnosis year
1983
percent
8.72
diagnosis year
1984
percent
9.95
diagnosis year
1985
percent
12.84
diagnosis year
1986
percent
11.6

missing years

diagnosis year
2019
status
not_reported
source value
-
modeled value present
true
diagnosis year
2020
status
not_reported
source value
-
modeled value present
true
diagnosis year
2021
status
not_reported
source value
-
modeled value present
true
diagnosis year
2022
status
not_reported
source value
-
modeled value present
true
diagnosis year
2023
status
not_reported
source value
-
modeled value present
true
diagnosis year
2024
status
not_reported
source value
-
modeled value present
false

source table id

scrapeTable_01

confidence intervals

Source null

sample sizes

Source null

overall survival

metric

relative_survival

horizon years

percent

33.4

cohort

registry: SEER 21 (Excluding IL)
diagnosis years: 2016
2022
race: All races
sex: Both sexes
age range: Source null
age adjustment: Source null
source footnote: Based on data from SEER 21 (Excluding IL) 2016–2022. Gray figures represent those who have died from acute myeloid leukemia. Green figures represent those who have survived 5 years or more.
stage: All stages
demographic scope source: Category survival-trend footnote; pooled box source footnote retained separately

source element

statBox

stage survival

Source null

subtype survival

additional survival tables

availability

historical survival: available
overall survival: available
stage survival: not_published_on_this_page

reuse

public domain statement present: true
attribution: National Cancer Institute, SEER Cancer Stat Facts
source url: https://seer.cancer.gov/statfacts/html/amyl.html

limitations

Published aggregate registry statistics; no individual-level records.
Five-year relative survival is not overall survival, a treatment effect, or an individual prognosis.
Year-of-diagnosis trends are not survival curves across follow-up time.
Null age_range means no explicit age subgroup in the source; it does not mean age zero.
No survival age adjustment is asserted unless explicitly documented.
Do not join pooled current estimates onto annual historical trends: registry coverage and cohorts differ.

Preserved source evidence · Not medical advice